NEW YORK (GenomeWeb News) – Eagle Genomics, UK-based bioinformatics software and services provider, has closed a round of fundraising, during which it raised £590,000 ($917,000) of a planned £1million investment round that will be used to expand its offerings.

This round was led by Midven's Rainbow Seed Fund together with angel investments from Abcam CEO Jonathan Milner, Cambridge Angels, London Business Angels, Cambridge Capital Group, and other undisclosed participants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.